Abstract: The latest research has identified FGL1 as an immune inhibitory ligand of LAG-3, an immune inhibitory receptor that mediates T-cell suppression. Blocking FGL1/LAG-3 interaction improves anti-tumor immunity.Summary: Creative BioMart has currently developed FGL1 proteins from multiple species. Their binding activity with LAG-3 protein has been verified by functional ELISA.
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
IgY Antibody Against Covid-19
Comprehensive one-stop platform to accelerate research
Therapeutic Antibodies Targeting MUC1
Chemokine Signaling Pathway
Immunity Buster Herbal Plant : During Covid-19 Pandemic
Devanand Dongre, Om Kharde, Prafulla Tathe